Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials

January 2011
BMC Psychiatry;2011, Vol. 11 Issue 1, p101
Academic Journal
The article presents a study conducted by Armin Szegedi and colleagues to examine the effects of asenapine on depressive symptoms in manic-depressive persons experiencing acute manic or mixed episodes. The study shows that asenapine efficacy is superior to placebo as early as day two in the treatment of acute mania.


Related Articles

  • Sub-threshold depression and antidepressants use in a community sample: searching anxiety and finding bipolar disorder.  // BMC Psychiatry;2011, Vol. 11 Issue 1, p164 

    The article presents a research which examines whether antidepressants (ADs) are effective for treating people suffering from sub-threshold depression (SD). It is reported that, the researchers used tools like questionnaire on psychotropic drug consumption, to conduct the research. According to...

  • The Clinical Neuroscience of Post Stroke Depression. Haroon, Ebrahim; Kumar, Anand // Current Neuropharmacology;Oct2004, Vol. 2 Issue 4, p353 

    Post stroke depression or PSD is believed to occur in ten to forty percent of all patients who survive stroke. These mood disturbances overlap with primary major depressive disorder in terms of symptom profile, natural history and response to antidepressant medications. Cognitive changes,...

  • What Shapes Depressed Individuals' Pre-Treatment Expectation in Antidepressant Clinical Trials? Moses, Tally; Leuchter, Andrew F.; Cook, Ian; Abrams, Michelle // Internet Journal of Mental Health;2007, Vol. 3 Issue 2, p2 

    Objective: To examine the relationship between patients' treatment outcome expectation and a set of socio-demographic factors, clinical course variables, symptom severity, health locus of control, and Temperament and Character Inventory (TCI) dimensions. Method: Logistic regression analyses were...

  • Investigational Drug Shows Promise in the Treatment of Depression. Neff, Matthew; Massana, Juan // American Family Physician;11/15/1999, Vol. 60 Issue 8, p2360 

    Reports that the investigational drug reboxetine mesylate shows promise in the treatment of patients with depression. Subjects and methodology; Effects of the medication to patients; Information on how reboxetine works.

  • Disrupting the rhythm of depression: design and protocol of a randomized controlled trial on preventing relapse using brief cognitive therapy with or without antidepressants. Bockting, Claudi L. H.; Elgersma, Hermien J.; van Rijsbergen, Gerard D.; de Jonge, Peter; Ormel, Johan; Buskens, Erik; Stant, A. Dennis; de Jong, Peter J.; Peeters, Frenk P. M. L.; Huibers, Marcus J. H.; Arntz, Arnoud; Muris, Peter; Nolen, Willem A.; Schene, Aart H.; Hollon, Steven D. // BMC Psychiatry;2011, Vol. 11 Issue 1, p8 

    Background: Maintenance treatment with antidepressants is the leading strategy to prevent relapse and recurrence in patients with recurrent major depressive disorder (MDD) who have responded to acute treatment with antidepressants (AD). However, in clinical practice most patients (up to 70-80%)...

  • Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder. Tadić, André; Wagner, Stefanie; Gorbulev, Stanislav; Dahmen, Norbert; Hiemke, Christoph; Braus, Dieter F.; Lieb, Klaus // BMC Psychiatry;2011, Vol. 11 Issue 1, p16 

    Background: In Major Depressive Disorder (MDD), treatment outcomes with currently available strategies are often disappointing. Therefore, it is sensible to develop new strategies to increase remission rates in acutely depressed patients. Many studies reported that true drug response can be...

  • The effect of forewarning on the occurrence of side-effects and discontinuance of medication in patients on amitriptyline. Myers, E. D.; Calvert, E. J. // British Journal of Psychiatry;Apr73, Vol. 122 Issue 569, p461 

    The article discusses the study on the impact of prevising patients taking amitriptyline on its side-effects. It is believed that psychological factors are significant in identifying the harmful or good effects of drugs. In an amitriptyline trial, patients were asked to note down their...

  • Should We Treat Depression with drugs or psychological interventions? A Reply to Ioannidis. Davis, John M.; Giakas, William J.; Jie Qu; Prasad, Pavan; Leucht, Stefan // Philosophy, Ethics & Humanities in Medicine;2011, Vol. 6 Issue 1, p8 

    We reply to the Ioannidis's paper "Effectiveness of antidepressants; an evidence based myth constructed from a thousand controlled trials." We disagree that antidepressants have no greater efficacy than placebo. We present the efficacy from hundreds of trials in terms of the percentage of...

  • Clinical Trials: St. Johnswort and major depression: a critical review of the JAMA trial. Hoppe, Jill; Bergner, Paul // Medical Herbalism: A Journal for the Clinical Practitioner;Spring2001, Vol. 12 Issue 2, p15 

    The April 18, 2001 issue of the Journal of the American Medical Association (JAMA) published a clinical trial that concluded St. John's wort was "not effective for treatment of major depression" even though results were typical for antidepressant drugs trials using placebos. The trial, performed...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics